NasdaqGS - Delayed Quote USD

CareMax, Inc. (CMAX)

3.1200 +0.2550 (+8.90%)
At close: April 26 at 4:00 PM EDT
3.2300 +0.11 (+3.53%)
After hours: April 26 at 5:30 PM EDT
Key Events
Loading Chart for CMAX
DELL
  • Previous Close 2.8650
  • Open 2.8600
  • Bid 3.0000 x 100
  • Ask 3.2200 x 100
  • Day's Range 2.8600 - 3.3000
  • 52 Week Range 2.2350 - 126.0000
  • Volume 29,707
  • Avg. Volume 96,607
  • Market Cap (intraday) 11.865M
  • Beta (5Y Monthly) 0.80
  • PE Ratio (TTM) --
  • EPS (TTM) -183.2900
  • Earnings Date May 8, 2024 - May 13, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 33.60

CareMax, Inc. provides care and chronic disease management services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation; and services to children and adults through Medicaid programs, as well as through commercial insurance plans. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. It operates multi-specialty medical care centers in Florida, New York, Tennessee, and Texas. The company is headquartered in Miami, Florida.

www.caremax.com

1,450

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CMAX

Performance Overview: CMAX

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CMAX
79.12%
S&P 500
6.92%

1-Year Return

CMAX
95.63%
S&P 500
25.26%

3-Year Return

CMAX
99.17%
S&P 500
22.00%

5-Year Return

CMAX
--
S&P 500
55.44%

Compare To: CMAX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CMAX

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    11.86M

  • Enterprise Value

    438.46M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.02

  • Price/Book (mrq)

    0.19

  • Enterprise Value/Revenue

    0.58

  • Enterprise Value/EBITDA

    -0.74

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -90.98%

  • Return on Assets (ttm)

    -7.58%

  • Return on Equity (ttm)

    -200.69%

  • Revenue (ttm)

    751.1M

  • Net Income Avi to Common (ttm)

    -683.35M

  • Diluted EPS (ttm)

    -183.2900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    65.53M

  • Total Debt/Equity (mrq)

    800.62%

  • Levered Free Cash Flow (ttm)

    3.63M

Research Analysis: CMAX

Analyst Price Targets

3.00
33.60 Average
3.1200 Current
120.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: CMAX

Fair Value

3.1200 Current
 

Dividend Score

0 Low
CMAX
Sector Avg.
100 High
 

Hiring Score

0 Low
CMAX
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
CMAX
Sector Avg.
100 High
 

People Also Watch